Skip to main content
Signal8

Graves Kurt

SEC insider (Form 3/4/5 filer). CIK 0001406337. Director at Seres Therapeutics, Inc. (MCRB). 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 8, 2026. Located in CAMBRIDGE, MA.

Companies Graves Kurt has filed insider reports for

  • Seres Therapeutics, Inc. (MCRB): Director
Graves Kurt profile photo

Graves Kurt

CIK: 0001406337

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Seres Therapeutics, Inc. logo
MCRB

Seres Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Seres Therapeutics, Inc. logo
    MCRB

    Seres Therapeutics, Inc.

    Jul 8, 2026
    Award

    Stock Option (right to buy)

    Direct
    6.5K shares-
  • Seres Therapeutics, Inc. logo
    MCRB

    Seres Therapeutics, Inc.

    Apr 10, 2025
    Award

    Stock Option (right to buy)

    Direct
    100K shares-

1-2 of 2